Inovio Pharmaceuticals, Inc.

INO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$36,567$24,351$39,915$65,813
Short-Term Investments$14,236$23,198$28,447$28,300
Receivables$979$840$1,310$1,199
Inventory$0$0$0$0
Other Curr. Assets$3,399$4,307$2,222$2,517
Total Curr. Assets$55,180$52,697$71,894$97,830
Property Plant & Equip (Net)$9,697$10,446$11,090$11,774
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,496$3,085$2,309$1,614
Tax Assets$0$0$0$0
Other NC Assets$2,012$2,012$1,980$1,980
Total NC Assets$14,205$15,543$15,378$15,367
Other Assets$0$0$0$0
Total Assets$69,386$68,241$87,273$113,197
Liabilities
Payables$5,903$5,484$5,524$6,443
Short-Term Debt$2,738$2,656$2,576$2,497
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$61,182$23,568$19,227$26,386
Total Curr. Liab.$69,824$31,708$27,327$35,326
LT Debt$7,282$8,002$8,695$9,368
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$7,282$8,002$8,695$9,368
Other Liabilities$0$0$0$0
Cap. Leases$7,282$10,658$11,271$11,865
Total Liabilities$77,106$39,710$36,022$44,693
Equity
Pref Stock$0$0$0$0
Common Stock$54$37$37$36
Retained Earnings-$1,818,930-$1,773,433-$1,749,914-$1,730,219
AOCI-$647-$662-$661-$676
Other Equity$1,811,804$1,802,589$1,801,789$1,799,363
Total Equity-$7,720$28,531$51,251$68,504
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$69,386$68,241$87,273$113,197
Net Debt-$26,547-$13,693-$28,644-$53,948